🏥 治験ポータル
← 治験一覧に戻る

日本における滲出型加齢黄斑変性症(wAMD)患者の介護者の負担

基本情報

NCT ID
NCT02541084
ステータス
完了
試験のフェーズ
-
試験タイプ
観察
目標被験者数
72
治験依頼者名
Bayer

概要

This study aims at investigation of the caregiver burden of Wet Age-related Macular Degeneration (wAMD) patients and at the assessment of how much of caregiver burden could be reduced in transitioning from Pro Re Nata to proactive therapy especially in real-life rural settings where public transportations are not readily available.

対象疾患

Wet Macular Degeneration

介入

Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)(DRUG)

依頼者(Sponsor)